PhRMA’s Latest 2022 IRS Filing Shows Over $1.2 Million In Payments To Opponents of Medicare Drug Price Negotiations

PhRMA’s 2022 tax filing shows they funneled over $1.2 million to conservative groups working to block Medicare’s power to negotiate lower drug prices.

These groups, like Americans for Prosperity and the Competitive Enterprise Institute, repeated Big Pharma’s claims that high drug prices are about covering research costs, not corporate greed. PhRMA even backed the Alliance for Aging Research, which argued that lowering drug prices would hurt seniors’ access to vital treatments. This reveals how far Big Pharma is willing to go—and how much they’re willing to spend—to protect their profits and keep drug prices high.